(1)
Rischin, D.; Khushalani, N.; Schmults, C.; Guminski, A.; Chang, A. L.; Lewis, K.; Lim, A.; Hernandez-Aya, L.; Hughes, B.; Schadendorf, D.; Hauschild, A.; Stankevich, E.; Booth, J.; Yoo, S.-Y.; Chen, Z.; Okoye, E.; Lowy, I.; Fury, M.; Migden, M. Phase 2 Study of Cemiplimab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up. J of Skin 2020, 4, s124.